Expanding Oversight of Opioid Prescribing and Payment Act of 2018

Bill: 115-hr-5723
Sponsor: full_name: Rep. Tenney, Claudia [R-NY-22]
Introduced: 2018-05-09
Policy area: Health
Subjects: Congressional oversight

Drug trafficking and controlled substances

Drug, alcohol, tobacco use

Health information and medical records

Home and outpatient care

Hospital care

Medicare

Prescription drugs
Latest action: action_date: 2018-06-20
text: Received in the Senate and Read twice and referred to the Committee on Finance.

Summaries:
action_date: 2018-05-09
action_desc: Introduced in House
text: <p><b>Expanding Oversight of Opioid Prescribing and Payment Act of 2018</b></p> <p>This bill requires the Medicare Payment Advisory Commission to report to Congress on:&nbsp;(1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.</p>

action_date: 2018-06-19
action_desc: Passed House amended
text: <p><b>Expanding Oversight of Opioid Prescribing and Payment Act of 2018</b></p> <p>(Sec. 2) This bill requires the Medicare Payment Advisory Commission to report to Congress on:&nbsp;(1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.</p>

tv_txt: I 115th CONGRESS 2d Session H. R. 5723 IN THE HOUSE OF REPRESENTATIVES May 9, 2018 Ms. Tenney (for herself, Mr. McKinley , and Ms. DelBene ) introduced the following bill; which was referred to the Committee on Ways and Means , and in addition to the Committee on Energy and Commerce , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To require the Medicare Payment Advisory Commission to report on opioid payment, adverse incentives, and data under the Medicare program.

1. Short title This Act may be cited as the Expanding Oversight of Opioid Prescribing and Payment Act of 2018 . 2. Medicare Payment Advisory Commission report on opioid payment, adverse incentives, and data under the Medicare program Not later than March 15, 2019, the Medicare Payment Advisory Commission shall submit to Congress a report on, with respect to the Medicare program under title XVIII of the Social Security Act, the following: (1) A description of how the Medicare program pays for pain management treatments (both opioid and non-opioid pain management alternatives) in an inpatient and outpatient hospital setting. (2) The identification of incentives under the hospital inpatient prospective payment system under section 1886 of the Social Security Act ( 42 U.S.C. 1395ww ) and incentives under the hospital outpatient prospective payment system under section 1833(t) of such Act ( 42 U.S.C. 1395l(t) ) for prescribing opioids and incentives under each such system for prescribing non-opioid treatments, and recommendations as the Commission deems appropriate for addressing any of such incentives that are adverse incentives. (3) A description of how opioid use is tracked and monitored through Medicare claims data and other mechanisms and the identification of any areas in which further data and methods are needed for improving data and understanding of opioid use.

tv_txt: I 115th CONGRESS 2d Session H. R. 5723 IN THE HOUSE OF REPRESENTATIVES AN ACT To require the Medicare Payment Advisory Commission to report on opioid payment, adverse incentives, and data under the Medicare program.

1. Short title This Act may be cited as the Expanding Oversight of Opioid Prescribing and Payment Act of 2018 . 2. Medicare Payment Advisory Commission report on opioid payment, adverse incentives, and data under the Medicare program Not later than March 15, 2019, the Medicare Payment Advisory Commission shall submit to Congress a report on, with respect to the Medicare program under title XVIII of the Social Security Act, the following: (1) A description of how the Medicare program pays for pain management treatments (both opioid and non-opioid pain management alternatives) in both inpatient and outpatient hospital settings. (2) The identification of incentives under the hospital inpatient prospective payment system under section 1886 of the Social Security Act ( 42 U.S.C. 1395ww ) and incentives under the hospital outpatient prospective payment system under section 1833(t) of such Act ( 42 U.S.C. 1395l(t) ) for prescribing opioids and incentives under each such system for prescribing non-opioid treatments, and recommendations as the Commission deems appropriate for addressing any of such incentives that are adverse incentives. (3) A description of how opioid use is tracked and monitored through Medicare claims data and other mechanisms and the identification of any areas in which further data and methods are needed for improving data and understanding of opioid use. 3. No additional funds authorized No additional funds are authorized to be appropriated to carry out the requirements of this Act. Such requirements shall be carried out using amounts otherwise authorized to be appropriated.

Passed the House of Representatives June 19, 2018. Karen L. Haas, Clerk.

tv_txt: IIB 115th CONGRESS 2d Session H. R. 5723 IN THE SENATE OF THE UNITED STATES June 20, 2018 Received; read twice and referred to the Committee on Finance AN ACT To require the Medicare Payment Advisory Commission to report on opioid payment, adverse incentives, and data under the Medicare program.

1. Short title This Act may be cited as the Expanding Oversight of Opioid Prescribing and Payment Act of 2018 . 2. Medicare Payment Advisory Commission report on opioid payment, adverse incentives, and data under the Medicare program Not later than March 15, 2019, the Medicare Payment Advisory Commission shall submit to Congress a report on, with respect to the Medicare program under title XVIII of the Social Security Act, the following: (1) A description of how the Medicare program pays for pain management treatments (both opioid and non-opioid pain management alternatives) in both inpatient and outpatient hospital settings. (2) The identification of incentives under the hospital inpatient prospective payment system under section 1886 of the Social Security Act ( 42 U.S.C. 1395ww ) and incentives under the hospital outpatient prospective payment system under section 1833(t) of such Act ( 42 U.S.C. 1395l(t) ) for prescribing opioids and incentives under each such system for prescribing non-opioid treatments, and recommendations as the Commission deems appropriate for addressing any of such incentives that are adverse incentives. (3) A description of how opioid use is tracked and monitored through Medicare claims data and other mechanisms and the identification of any areas in which further data and methods are needed for improving data and understanding of opioid use. 3. No additional funds authorized No additional funds are authorized to be appropriated to carry out the requirements of this Act. Such requirements shall be carried out using amounts otherwise authorized to be appropriated.

Passed the House of Representatives June 19, 2018. Karen L. Haas, Clerk

tv_txt: IB Union Calendar No. 592 115th CONGRESS 2d Session H. R. 5723 [Report No. 115–760, Part I] IN THE HOUSE OF REPRESENTATIVES May 9, 2018 Ms. Tenney (for herself, Mr. McKinley , and Ms. DelBene ) introduced the following bill; which was referred to the Committee on Ways and Means , and in addition to the Committee on Energy and Commerce , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned June 19, 2018 Additional sponsors: Mr. Renacci and Mr. Sanford June 19, 2018 Reported from the Committee on Ways and Means with an amendment Strike out all after the enacting clause and insert the part printed in italic June 19, 2018 Committee on Energy and Commerce discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed For text of introduced bill, see copy of bill as introduced on May 9, 2018 A BILL To require the Medicare Payment Advisory Commission to report on opioid payment, adverse incentives, and data under the Medicare program.

1. Short title This Act may be cited as the Expanding Oversight of Opioid Prescribing and Payment Act of 2018 . 2. Medicare Payment Advisory Commission report on opioid payment, adverse incentives, and data under the Medicare program Not later than March 15, 2019, the Medicare Payment Advisory Commission shall submit to Congress a report on, with respect to the Medicare program under title XVIII of the Social Security Act, the following: (1) A description of how the Medicare program pays for pain management treatments (both opioid and non-opioid pain management alternatives) in both inpatient and outpatient hospital settings. (2) The identification of incentives under the hospital inpatient prospective payment system under section 1886 of the Social Security Act ( 42 U.S.C. 1395ww ) and incentives under the hospital outpatient prospective payment system under section 1833(t) of such Act ( 42 U.S.C. 1395l(t) ) for prescribing opioids and incentives under each such system for prescribing non-opioid treatments, and recommendations as the Commission deems appropriate for addressing any of such incentives that are adverse incentives. (3) A description of how opioid use is tracked and monitored through Medicare claims data and other mechanisms and the identification of any areas in which further data and methods are needed for improving data and understanding of opioid use.

June 19, 2018 Reported from the Committee on Ways and Means with an amendment June 19, 2018 Committee on Energy and Commerce discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed